154 related articles for article (PubMed ID: 15517878)
1. Cyclooxygenase-2 gene induction causes CDDP resistance in colon cancer cell line, HCT-15.
Saikawa Y; Sugiura T; Toriumi F; Kubota T; Suganuma K; Isshiki S; Otani Y; Kumai K; Kitajima M
Anticancer Res; 2004; 24(5A):2723-8. PubMed ID: 15517878
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?
Ratnasinghe D; Daschner PJ; Anver MR; Kasprzak BH; Taylor PR; Yeh GC; Tangrea JA
Anticancer Res; 2001; 21(3C):2141-7. PubMed ID: 11501838
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
[TBL] [Abstract][Full Text] [Related]
4. Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522.
Mizutani Y; Nakanishi H; Li YN; Sato N; Kawauchi A; Miki T
J Urol; 2004 Oct; 172(4 Pt 1):1474-9. PubMed ID: 15371874
[TBL] [Abstract][Full Text] [Related]
5. JTE-522, a selective COX-2 inhibitor, inhibits cell proliferation and induces apoptosis in RL95-2 cells.
Li HL; Zhang HW; Chen DD; Zhong L; Ren XD; St-Tu R
Acta Pharmacol Sin; 2002 Jul; 23(7):631-7. PubMed ID: 12100758
[TBL] [Abstract][Full Text] [Related]
6. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
[TBL] [Abstract][Full Text] [Related]
7. Induction of multidrug resistance proteins MRP1 and MRP3 and gamma-glutamylcysteine synthetase gene expression by nonsteroidal anti-inflammatory drugs in human colon cancer cells.
Tatebe S; Sinicrope FA; Kuo MT
Biochem Biophys Res Commun; 2002 Feb; 290(5):1427-33. PubMed ID: 11820781
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of stepwise and pulse induced cisplatin-resistant ovarian cancer cell sublines].
Cheng G; Li Y; Tian F
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):305-8. PubMed ID: 11783113
[TBL] [Abstract][Full Text] [Related]
9. Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer.
Mizutani Y; Kamoi K; Ukimura O; Kawauchi A; Miki T
J Urol; 2002 Dec; 168(6):2650-4. PubMed ID: 12442003
[TBL] [Abstract][Full Text] [Related]
10. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells.
Tang X; Sun YJ; Half E; Kuo MT; Sinicrope F
Cancer Res; 2002 Sep; 62(17):4903-8. PubMed ID: 12208739
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines.
Uefuji K; Ichikura T; Shinomiya N; Mochizuki H
Anticancer Res; 2000; 20(6B):4279-84. PubMed ID: 11205258
[TBL] [Abstract][Full Text] [Related]
13. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells.
Liu CY; Lai YY; Lo CJ
J Surg Res; 2004 Apr; 117(2):223-31. PubMed ID: 15047127
[TBL] [Abstract][Full Text] [Related]
14. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor.
Li Z; Shimada Y; Kawabe A; Sato F; Maeda M; Komoto I; Hong T; Ding Y; Kaganoi J; Imamura M
Carcinogenesis; 2001 Apr; 22(4):547-51. PubMed ID: 11285187
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of cisplatin-induced multidrug resistant human epithelial ovarian cancer cell line 3AO/cDDP and its expressions of multidrug resistance proteins].
Chen J; Yang R; Liu F
Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):617-20. PubMed ID: 11372415
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer.
Nagatsuka I; Yamada N; Shimizu S; Ohira M; Nishino H; Seki S; Hirakawa K
Int J Cancer; 2002 Aug; 100(5):515-9. PubMed ID: 12124799
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced increases in A549/CDDP cell drug resistance are reversed by RNA interference of HIF-1α expression.
Min L; Chen Q; He S; Liu S; Ma Y
Mol Med Rep; 2012 Jan; 5(1):228-32. PubMed ID: 21964646
[TBL] [Abstract][Full Text] [Related]
18. [Establishment and drug-resistance gene expression of cisplatin-resistant cell line Tca8113/CDDP].
Zhou XJ; Li Q; Chen WT
Shanghai Kou Qiang Yi Xue; 2003 Dec; 12(6):432-5. PubMed ID: 14966583
[TBL] [Abstract][Full Text] [Related]
19. Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer.
Noma B; Sasaki T; Fujimoto Y; Serikawa M; Kobayashi K; Inoue M; Itsuki H; Kamigaki M; Minami T; Chayama K
Int J Oncol; 2008 Dec; 33(6):1187-94. PubMed ID: 19020751
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
